PL1765342T3 - Kompozycja farmaceutyczna zawierająca besylan amlodypiny i dihydrat lizynoprylu oraz sposób jej wytwarzania - Google Patents

Kompozycja farmaceutyczna zawierająca besylan amlodypiny i dihydrat lizynoprylu oraz sposób jej wytwarzania

Info

Publication number: PL1765342T3
Authority: PL; Poland
Prior art keywords: preparation; pharmaceutical composition; lisinopril dihydrate; amlodipine besilate; besilate
Prior art date: 2004-06-10

Application number

PL05751188T

Other languages

English (en)

Other versions

PL1765342T4 (pl

Inventor

Ákos Kelen

Original Assignee

Richter Gedeon Nyrt

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-06-10

Filing date

2005-06-09

Publication date

2011-04-29

2005-06-09 Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt

2011-04-29 Publication of PL1765342T3 publication Critical patent/PL1765342T3/pl

2022-11-07 Publication of PL1765342T4 publication Critical patent/PL1765342T4/pl

Links

229960002394 lisinopril Drugs 0.000 title abstract 2
RLAWWYSOJDYHDC-BZSNNMDCSA-N lisinopril Chemical compound C([C@H](N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(O)=O)C(O)=O)CC1=CC=CC=C1 RLAWWYSOJDYHDC-BZSNNMDCSA-N 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title abstract 2
229960000528 amlodipine Drugs 0.000 title 1
HTIQEAQVCYTUBX-UHFFFAOYSA-N amlodipine Chemical compound CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1Cl HTIQEAQVCYTUBX-UHFFFAOYSA-N 0.000 title 1
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 abstract 2
239000000546 pharmaceutical excipient Substances 0.000 abstract 2
239000004480 active ingredient Substances 0.000 abstract 1
229910000147 aluminium phosphate Inorganic materials 0.000 abstract 1
SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 abstract 1
229950004221 besilate Drugs 0.000 abstract 1
159000000007 calcium salts Chemical class 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PL05751188.3T 2004-06-10 2005-06-09 Kompozycja farmaceutyczna zawierająca besylan amlodypiny i dihydrat lizynoprylu oraz sposób jej wytwarzania PL1765342T4 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
HU0401170A HUP0401170A2 (en)	2004-06-10	2004-06-10	Pharmaceutical composition comprising amlodipine besilate and lisinopril dihydrate and process for
EP05751188A EP1765342B9 (en)	2004-06-10	2005-06-09	Pharmaceutical composition comprising amlodipine besilate and lisinopril dihydrate and process for the preparation thereof
PCT/HU2005/000064 WO2005120502A1 (en)	2004-06-10	2005-06-09	New pharmaceutical composition and process for the preparation thereof

Publications (2)

Publication Number	Publication Date
PL1765342T3 true PL1765342T3 (pl)	2011-04-29
PL1765342T4 PL1765342T4 (pl)	2022-11-07

Family

ID=89985289

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL05751188.3T PL1765342T4 (pl)	2004-06-10	2005-06-09	Kompozycja farmaceutyczna zawierająca besylan amlodypiny i dihydrat lizynoprylu oraz sposób jej wytwarzania

Country Status (15)

Country	Link
EP (1)	EP1765342B9 (pl)
AT (1)	ATE486599T1 (pl)
CY (1)	CY1111484T1 (pl)
DE (1)	DE602005024554D1 (pl)
DK (1)	DK1765342T3 (pl)
EA (1)	EA010288B1 (pl)
ES (1)	ES2354618T3 (pl)
HR (1)	HRP20110034T1 (pl)
HU (2)	HUP0401170A2 (pl)
ME (1)	ME01935B (pl)
PL (1)	PL1765342T4 (pl)
PT (1)	PT1765342E (pl)
RS (1)	RS51677B (pl)
SI (1)	SI1765342T1 (pl)
WO (1)	WO2005120502A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2011104588A2 (en) *	2010-02-24	2011-09-01	Sanofi-Aventis Deutschland Gmbh	Solid pharmaceutical formulations of ramipril and amlodipine besylate, and their preparation
RU2483728C1 (ru) *	2011-09-29	2013-06-10	Общество с ограниченной ответственностью "Озон"	Комбинированное гипотензивное средство и способ его получения
PL227900B1 (pl) *	2012-11-15	2018-01-31	Adamed Spolka Z Ograniczona Odpowiedzialnoscia	Kompozycja farmaceutyczna zawierająca inhibitor ACE i bloker kanałów wapniowych, sposób jej wytwarzania i jednostka dawkowania zawierająca tę kompozycję
CN105194647A (zh) *	2014-06-30	2015-12-30	南京瑞尔医药有限公司	一种含有赖诺普利和苯磺酸氨氯地平的药物组合物及其制备方法
CN106333948A (zh) *	2016-08-23	2017-01-18	成都尚药科技有限公司	含有苯磺酸氨氯地平和二水合赖诺普利的药物及制备方法
AU2018258170B2 (en) *	2017-04-25	2023-06-29	Otsuka Pharmaceutical Co., Ltd.	Lisinopril compositions with an ingestible event marker
GB2595203A (en)	2020-03-03	2021-11-24	Alkaloid Ad Skopje	Formulation
IL319228A (en) *	2022-09-07	2025-04-01	Lasse Kinast	Immediate-release oral pharmaceutical dosage form of amlodipine with increased API quantity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE235251T1 (de) *	1995-03-16	2003-04-15	Pfizer	Verwendung von amlodipin, eines seiner salze oder felodipin in kombination mit einem ace-hemmer zur herstellung eines arzneimittels zur behandlung von nicht ischämischer kongestiver herzinsuffizienz
HUP0202416A3 (en)	2002-07-24	2006-01-30	Richter Gedeon Vegyeszet	Novel pharmaceutical combination and it's use for the treatment of certain cardiovascular disorders

2004
- 2004-06-10 HU HU0401170A patent/HUP0401170A2/hu unknown
2005
- 2005-06-09 ES ES05751188T patent/ES2354618T3/es not_active Expired - Lifetime
- 2005-06-09 DE DE602005024554T patent/DE602005024554D1/de not_active Expired - Lifetime
- 2005-06-09 AT AT05751188T patent/ATE486599T1/de active
- 2005-06-09 EA EA200602187A patent/EA010288B1/ru unknown
- 2005-06-09 PT PT05751188T patent/PT1765342E/pt unknown
- 2005-06-09 RS RS20100496A patent/RS51677B/sr unknown
- 2005-06-09 ME MEP-2010-496A patent/ME01935B/me unknown
- 2005-06-09 HR HR20110034T patent/HRP20110034T1/hr unknown
- 2005-06-09 DK DK05751188.3T patent/DK1765342T3/da active
- 2005-06-09 PL PL05751188.3T patent/PL1765342T4/pl unknown
- 2005-06-09 HU HUE05751188A patent/HUE009867T4/hu unknown
- 2005-06-09 WO PCT/HU2005/000064 patent/WO2005120502A1/en not_active Ceased
- 2005-06-09 EP EP05751188A patent/EP1765342B9/en not_active Expired - Lifetime
- 2005-06-09 SI SI200531194T patent/SI1765342T1/sl unknown
2010
- 2010-12-30 CY CY20101101203T patent/CY1111484T1/el unknown

Also Published As

Publication number	Publication date
DK1765342T3 (da)	2011-01-24
EA200602187A1 (ru)	2007-04-27
EA010288B1 (ru)	2008-08-29
HRP20110034T1 (hr)	2011-02-28
PT1765342E (pt)	2010-12-20
EP1765342B9 (en)	2011-02-23
HUE009867T4 (hu)	2022-01-28
ATE486599T1 (de)	2010-11-15
ES2354618T3 (es)	2011-03-16
DE602005024554D1 (de)	2010-12-16
SI1765342T1 (sl)	2011-02-28
ME01935B (me)	2011-10-31
HUP0401170A2 (en)	2006-09-28
CY1111484T1 (el)	2015-08-05
WO2005120502A1 (en)	2005-12-22
RS51677B (sr)	2011-10-31
EP1765342A1 (en)	2007-03-28
PL1765342T4 (pl)	2022-11-07
HU0401170D0 (en)	2004-08-30
EP1765342B1 (en)	2010-11-03
HUE009867T2 (pl)	2011-05-30

Similar Documents

Publication	Publication Date	Title
MY144992A (en)	2011-12-15	Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
BRPI0508579A (pt)	2007-08-14	composto, composição farmacêutica, e, uso de um composto
YU69603A (sh)	2006-05-25	Atorvastatin kalcijum u farmaceutskom obliku, njegovoj smeši i farmaceutskoj formulaciji, koja sadrži atorvastatin kalcijum
TW200514772A (en)	2005-05-01	Novel tetrahydropyridine derivatives
WO2004033418A3 (en)	2004-06-03	Sulfonylamino-acetic derivatives and their use as orexin receptor antagonists
IL158589A (en)	2010-11-30	Carboxylic acid substituted oxazole derivatives, process for their manufacture, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for the treatment and prophylaxis of diseases which are modulated by ppar-alpha and -gamma activators
MY143795A (en)	2011-07-15	Tetrahydropyridoindole derivatives
BRPI0408439A (pt)	2006-04-04	composição farmacêutica lìquida aquosa, método para preparar e uso da mesma, método para tratar uma sìndrome responsiva ao fator vii, e, recipiente hermético
CY1111484T1 (el)	2015-08-05	Φαρμακευτικη συνθεση που περιεχει αμλοδιπινη βεσυλικη και λισινοπριλη διυδρικη και μεθοδος παρασκευης αυτης
DK1897558T3 (da)	2013-12-09	Fast præparat af 2-hexadecyloxy-6-methyl-4h-3,1-benzoxazin-4-on
WO2005054244A3 (en)	2005-08-04	Azabicyclooctene and other tetrahydropyridine derivatives with a new side-chain
MXPA05011497A (es)	2005-12-15	Derivados de tropano y su uso como inhibidores de la enzima de conversion de angiotensina (ace).
WO2003050067A3 (fr)	2004-03-04	Analogues de la vitamine d
PT1047413E (pt)	2011-10-13	Composição farmacêutica incluindo pelo menos um inibidor da aminopeptidase a
TW200621773A (en)	2006-07-01	Bicyclononene derivatives
MXPA04005033A (es)	2004-08-11	Composicion farmaceutica que comprende una combinacion de metformina y acido 4-oxobutanoico y el uso de la misma para el tratamiento contra diabetes.
TW200628468A (en)	2006-08-16	Bicyclononene derivatives
WO2004093867A3 (en)	2004-12-02	Phenolic acid salts of gabapentin in liquid and/or semi-solid dosage forms and methods of use
WO2023150790A3 (en)	2023-10-26	Novel and highly selective sars-cov-2 mpro inhibitors
TW200621774A (en)	2006-07-01	Bicyclononene derivatives
PT1432407E (pt)	2005-05-31	Composicoes de lisinopril que possuem dcpd de particulas grandes
WO2006021399A3 (en)	2006-10-26	Azabicyclononene derivatives as renin inhibitors
PT1815850E (pt)	2009-01-06	Formulação de libertação controlada de ácido divalpróico e seus derivados
WO2003011773A3 (en)	2003-09-25	Solid free-flowing phosphonate composition and method of use
TW200518749A (en)	2005-06-16	Stabilised pharmaceutical compositions